Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

BACKGROUND: Definitive radiotherapy plus concurrent chemotherapy has been a standard treatment for esophagus patients who are unfit to undergo surgery. However, there are a variety of concurrent chemotherapy regimens with varying efficacy. In this phase II prospective study, we compared the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hui, Makelike, Kanjiebubi, Chen, Baoqing, Xi, Mian, Li, Qiaoqiao, Hu, Yonghong, Zhu, Yujia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498519/
https://www.ncbi.nlm.nih.gov/pubmed/37700348
http://dx.doi.org/10.1186/s13014-023-02339-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498519/
https://www.ncbi.nlm.nih.gov/pubmed/37700348
http://dx.doi.org/10.1186/s13014-023-02339-9

Ejemplares similares